APA (7th ed.) Citation

JA, C., W, Y., NC, W., DD, S., BH, B., G, D., . . . DF, B. (2023). Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(8), 1618. https://doi.org/10.1200/JCO.22.00763

Chicago Style (17th ed.) Citation

JA, Coleman, et al. "Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 41, no. 8 (2023): 1618. https://doi.org/10.1200/JCO.22.00763.

MLA (9th ed.) Citation

JA, Coleman, et al. "Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 41, no. 8, 2023, p. 1618, https://doi.org/10.1200/JCO.22.00763.